ScoreWhy is Indoco Remedies Ltd ?
1
Weak Long Term Fundamental Strength with a -28.83% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.69 times
- The company has been able to generate a Return on Equity (avg) of 7.83% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 15 consecutive quarters
- INTEREST(Latest six months) At Rs 74.21 cr has Grown at 47.83%
- DEBT-EQUITY RATIO(HY) Highest at 1.16 times
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.67 times
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -30.74% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Indoco Remedies for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Indoco Remedies
-30.74%
-0.64
47.95%
Sensex
-3.81%
-0.28
13.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.73%
EBIT Growth (5y)
-28.83%
EBIT to Interest (avg)
5.31
Debt to EBITDA (avg)
4.43
Net Debt to Equity (avg)
1.13
Sales to Capital Employed (avg)
1.08
Tax Ratio
60.66%
Dividend Payout Ratio
-2.50%
Pledged Shares
0
Institutional Holding
18.95%
ROCE (avg)
10.05%
ROE (avg)
7.83%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
37
Price to Book Value
2.15
EV to EBIT
90.58
EV to EBITDA
18.64
EV to Capital Employed
1.54
EV to Sales
1.64
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
0.77%
ROE (Latest)
-9.82%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
EPS(Q)
Highest at Rs 7.04
-10What is not working for the Company
INTEREST(Latest six months)
At Rs 74.21 cr has Grown at 47.83%
DEBT-EQUITY RATIO(HY)
Highest at 1.16 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.67 times
Loading Valuation Snapshot...
Here's what is working for Indoco Remedies
Earnings per Share (EPS) - Quarterly
Highest at Rs 7.04
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Indoco Remedies
Interest - Latest six months
At Rs 74.21 cr has Grown at 47.83%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Debt-Equity Ratio - Half Yearly
Highest at 1.16 times and Grown
each half year in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio- Half Yearly
Lowest at 3.67 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
Highest at Rs 2.18 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
